117 related articles for article (PubMed ID: 37172667)
1. Serum TCA cycle metabolites in Lewy bodies dementia and Alzheimer's disease: Network analysis and cognitive prognosis.
Jaramillo-Jimenez A; Giil LM; Borda MG; Tovar-Rios DA; Kristiansen KA; Bruheim P; Aarsland D; Barreto GE; Berge RK
Mitochondrion; 2023 Jul; 71():17-25. PubMed ID: 37172667
[TBL] [Abstract][Full Text] [Related]
2. Greater Variability in Cognitive Decline in Lewy Body Dementia Compared to Alzheimer's Disease.
Giil LM; Aarsland D
J Alzheimers Dis; 2020; 73(4):1321-1330. PubMed ID: 31903991
[TBL] [Abstract][Full Text] [Related]
3. Components of the choline oxidation pathway modify the association between the apolipoprotein ε4 gene variant and cognitive decline in patients with dementia.
Hildre AS; Solvang SH; Aarsland D; Midtun Ø; McCann A; Ervik AO; Nygård O; Ueland PM; Nordrehaug JE; Giil LM
Brain Res; 2020 Jan; 1726():146519. PubMed ID: 31654640
[TBL] [Abstract][Full Text] [Related]
4. The
Saeed U; Desmarais P; Masellis M
Expert Rev Neurother; 2021 Aug; 21(8):851-870. PubMed ID: 34311631
[No Abstract] [Full Text] [Related]
5. Serum tyrosine is associated with better cognition in Lewy body dementia.
McCann A; Aarsland D; Ueland PM; Solvang SH; Nordrehaug JE; Giil LM
Brain Res; 2021 Aug; 1765():147481. PubMed ID: 33865805
[TBL] [Abstract][Full Text] [Related]
6.
Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M;
Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706
[TBL] [Abstract][Full Text] [Related]
7. APOE-ε4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies.
Saeed U; Mirza SS; MacIntosh BJ; Herrmann N; Keith J; Ramirez J; Nestor SM; Yu Q; Knight J; Swardfager W; Potkin SG; Rogaeva E; St George-Hyslop P; Black SE; Masellis M
Alzheimers Dement; 2018 Sep; 14(9):1137-1147. PubMed ID: 29782824
[TBL] [Abstract][Full Text] [Related]
8. APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk.
Borroni B; Grassi M; Costanzi C; Archetti S; Caimi L; Padovani A
Am J Geriatr Psychiatry; 2006 Dec; 14(12):1022-31. PubMed ID: 16956959
[TBL] [Abstract][Full Text] [Related]
9. Associations between APOE polymorphisms and seven diseases with cognitive impairment including Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies in southeast China.
Chen KL; Sun YM; Zhou Y; Zhao QH; Ding D; Guo QH
Psychiatr Genet; 2016 Jun; 26(3):124-31. PubMed ID: 26981880
[TBL] [Abstract][Full Text] [Related]
10. Serum Potassium Is Associated with Cognitive Decline in Patients with Lewy Body Dementia.
Giil LM; Solvang SH; Giil MM; Hellton KH; Skogseth RE; Vik-Mo AO; Hortobágyi T; Aarsland D; Nordrehaug JE
J Alzheimers Dis; 2019; 68(1):239-253. PubMed ID: 30775974
[TBL] [Abstract][Full Text] [Related]
11. The presence and co-incidence of geriatric syndromes in older patients with mild-moderate Lewy body dementia.
Gan J; Chen Z; Liu S; Shi Z; Liu Y; Wang XD; Liu C; Ji Y
BMC Neurol; 2022 Sep; 22(1):355. PubMed ID: 36123648
[TBL] [Abstract][Full Text] [Related]
12. High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia.
Vijayaraghavan S; Maetzler W; Reimold M; Lithner CU; Liepelt-Scarfone I; Berg D; Darreh-Shori T
Alzheimers Dement; 2014 Sep; 10(5):530-540.e1. PubMed ID: 23978325
[TBL] [Abstract][Full Text] [Related]
13. Impact of APOE ε4 genotype on initial cognitive symptoms differs for Alzheimer's and Lewy body neuropathology.
Pillai JA; Bena J; Bonner-Jackson A; Leverenz JB
Alzheimers Res Ther; 2021 Jan; 13(1):31. PubMed ID: 33485373
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia.
Abdelnour C; van Steenoven I; Londos E; Blanc F; Auestad B; Kramberger MG; Zetterberg H; Mollenhauer B; Boada M; Aarsland D;
Mov Disord; 2016 Aug; 31(8):1203-8. PubMed ID: 27296778
[TBL] [Abstract][Full Text] [Related]
15. Assessment of APOE in atypical parkinsonism syndromes.
Sabir MS; Blauwendraat C; Ahmed S; Serrano GE; Beach TG; Perkins M; Rice AC; Masliah E; Morris CM; Pihlstrom L; Pantelyat A; Resnick SM; Cookson MR; Hernandez DG; Albert M; Dawson TM; Rosenthal LS; Houlden H; Pletnikova O; Troncoso J; Scholz SW
Neurobiol Dis; 2019 Jul; 127():142-146. PubMed ID: 30798004
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychiatric Symptoms and Functional Decline in Alzheimer's Disease and Lewy Body Dementia.
Borda MG; Aarsland D; Tovar-Rios DA; Giil LM; Ballard C; Gonzalez MC; Brønnick K; Alves G; Oppedal K; Soennesyn H; Vik-Mo AO
J Am Geriatr Soc; 2020 Oct; 68(10):2257-2263. PubMed ID: 32738062
[TBL] [Abstract][Full Text] [Related]
17. Prodromal Dementia With Lewy Bodies: Clinical Characterization and Predictors of Progression.
van de Beek M; van Steenoven I; van der Zande JJ; Barkhof F; Teunissen CE; van der Flier WM; Lemstra AW
Mov Disord; 2020 May; 35(5):859-867. PubMed ID: 32048343
[TBL] [Abstract][Full Text] [Related]
18. Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia.
Bergland AK; Dalen I; Larsen AI; Aarsland D; Soennesyn H
J Alzheimers Dis; 2017; 56(2):575-584. PubMed ID: 28035932
[TBL] [Abstract][Full Text] [Related]
19. The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease.
Ballard C; O'Brien J; Morris CM; Barber R; Swann A; Neill D; McKeith I
Int J Geriatr Psychiatry; 2001 May; 16(5):499-503. PubMed ID: 11376466
[TBL] [Abstract][Full Text] [Related]
20. Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups.
Kaivola K; Shah Z; Chia R; ; Scholz SW
Brain; 2022 Jun; 145(5):1757-1762. PubMed ID: 35381062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
